Literature DB >> 35657618

Mechanisms that limit regression of myocardial fibrosis following removal of left ventricular pressure overload.

Lily S Neff1, Yuhua Zhang1, An O Van Laer1, Catalin F Baicu1, Mark Karavan1, Michael R Zile1,2, Amy D Bradshaw1,2.   

Abstract

Left ventricular pressure overload (LVPO) can develop from antecedent diseases such as aortic valve stenosis and systemic hypertension and is characterized by accumulation of myocardial extracellular matrix (ECM). Evidence from patient and animal models supports limited reductions in ECM following alleviation of PO, however, mechanisms that control the extent and timing of ECM regression are undefined. LVPO, induced by 4 wk of transverse aortic constriction (TAC) in mice, was alleviated by removal of the band (unTAC). Cardiomyocyte cross-sectional area, collagen volume fraction (CVF), myocardial stiffness, and collagen degradation were assessed for: control, 2-wk TAC, 4-wk TAC, 4-wk TAC + 2-wk unTAC, 4-wk TAC + 4-wk unTAC, and 4-wk TAC + 6-wk unTAC. When compared with 4-wk TAC, 2-wk unTAC resulted in increased reactivity of collagen hybridizing peptide (CHP) (representing initiation of collagen degradation), increased levels of collagenases and gelatinases, decreased levels of collagen cross-linking enzymes, but no change in CVF. When compared with 2-wk unTAC, 4-wk unTAC demonstrated decreased CVF, which did not decline to control values. At 4-wk and 6-wk unTAC, CHP reactivity and mediators of ECM degradation were reduced versus 2-wk unTAC, whereas levels of tissue inhibitor of metalloproteinase (TIMP)-1 increased. ECM homeostasis changed in a time-dependent manner after removal of LVPO and is characterized by early increases in collagen degradation, followed by a later dampening of this process. Tempered ECM degradation with time is predicted to contribute to the finding that normalization of hemodynamic overload alone does not completely regress myocardial fibrosis.NEW & NOTEWORTHY In this study, a murine model demonstrated persistent interstitial fibrosis and myocardial stiffness following alleviation of pressure overload.

Entities:  

Keywords:  LVPO; collagen cross-linking; collagen degradation; fibrosis; heart failure

Mesh:

Substances:

Year:  2022        PMID: 35657618      PMCID: PMC9236876          DOI: 10.1152/ajpheart.00148.2022

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   5.125


  26 in total

Review 1.  Collagen Fibril Assembly and Function.

Authors:  David F Holmes; Yinhui Lu; Tobias Starborg; Karl E Kadler
Journal:  Curr Top Dev Biol       Date:  2018-03-21       Impact factor: 4.897

Review 2.  Interstitial collagen catabolism.

Authors:  Gregg B Fields
Journal:  J Biol Chem       Date:  2013-02-19       Impact factor: 5.157

Review 3.  Lysyl oxidases: from enzyme activity to extracellular matrix cross-links.

Authors:  Sylvain D Vallet; Sylvie Ricard-Blum
Journal:  Essays Biochem       Date:  2019-09-13       Impact factor: 8.000

4.  Normalization of left ventricular nonuniformity late after valve replacement for aortic stenosis.

Authors:  B Villari; G Vassalli; S Betocchi; C Briguori; M Chiariello; O M Hess
Journal:  Am J Cardiol       Date:  1996-07-01       Impact factor: 2.778

5.  Tissue Inhibitor of Matrix Metalloproteinase-1 Promotes Myocardial Fibrosis by Mediating CD63-Integrin β1 Interaction.

Authors:  Abhijit Takawale; Pu Zhang; Vaibhav B Patel; Xiuhua Wang; Gavin Oudit; Zamaneh Kassiri
Journal:  Hypertension       Date:  2017-04-03       Impact factor: 10.190

6.  Pressure overload generates a cardiac-specific profile of inflammatory mediators.

Authors:  Matthew O'Brien; Catalin F Baicu; An O Van Laer; Yuhua Zhang; Lindsey T McDonald; Amanda C LaRue; Michael R Zile; Amy D Bradshaw
Journal:  Am J Physiol Heart Circ Physiol       Date:  2020-06-26       Impact factor: 4.733

7.  Diastolic stiffness and myocardial structure in aortic valve disease before and after valve replacement.

Authors:  O M Hess; M Ritter; J Schneider; J Grimm; M Turina; H P Krayenbuehl
Journal:  Circulation       Date:  1984-05       Impact factor: 29.690

Review 8.  Cross your heart? Collagen cross-links in cardiac health and disease.

Authors:  Lily S Neff; Amy D Bradshaw
Journal:  Cell Signal       Date:  2020-12-29       Impact factor: 4.315

9.  Characterization of biventricular alterations in myocardial (reverse) remodelling in aortic banding-induced chronic pressure overload.

Authors:  Daniela Miranda-Silva; Patrícia Gonçalves-Rodrigues; João Almeida-Coelho; Nazha Hamdani; Tânia Lima; Glória Conceição; Cláudia Sousa-Mendes; Arantxa González; Javier Díez; Wolfgang A Linke; Adelino Leite-Moreira; Inês Falcão-Pires
Journal:  Sci Rep       Date:  2019-02-27       Impact factor: 4.379

10.  Targeting LOXL2 for cardiac interstitial fibrosis and heart failure treatment.

Authors:  Jin Yang; Konstantinos Savvatis; Jong Seok Kang; Peidong Fan; Hongyan Zhong; Karen Schwartz; Vivian Barry; Amanda Mikels-Vigdal; Serge Karpinski; Dmytro Kornyeyev; Joanne Adamkewicz; Xuhui Feng; Qiong Zhou; Ching Shang; Praveen Kumar; Dillon Phan; Mario Kasner; Begoña López; Javier Diez; Keith C Wright; Roxanne L Kovacs; Peng-Sheng Chen; Thomas Quertermous; Victoria Smith; Lina Yao; Carsten Tschöpe; Ching-Pin Chang
Journal:  Nat Commun       Date:  2016-12-14       Impact factor: 14.919

View more
  1 in total

1.  And the band played on: persistent fibrosis after unbanding reveals sex-dependent differences in rats.

Authors:  Michael R Zile; Amy D Bradshaw
Journal:  Am J Physiol Heart Circ Physiol       Date:  2022-07-15       Impact factor: 5.125

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.